ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)

Diabetes represents a pro-thrombotic condition. The primary objective was to evaluate the effects of Vitamin K Antagonist (VKA) compared to direct oral anticoagulants (DOACs) in diabetic and nondiabetic patients with non-valvular atrial fibrillation, newly diagnosed. The secondary objective was to e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes and its complications 2023-08, Vol.37 (8), p.108512-108512, Article 108512
Hauptverfasser:	Derosa, Giuseppe, Rizzo, Manfredi, Brunetti, Natale Daniele, Raddino, Riccardo, Gavazzoni, Mara, Pasini, Gianfranco, Gaudio, Giovanni, Maggi, Antonio, D'Angelo, Angela, De Gennaro, Luisa, Maffioli, Pamela
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anticoagulants Anticoagulants - adverse effects Atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Atrial Fibrillation - epidemiology Body mass index Cardiac arrhythmia Cholesterol Creatinine Dabigatran - adverse effects Diabetes Diabetes Mellitus - drug therapy Diabetes Mellitus - epidemiology DOACs Drug dosages Embolisms Glucose Hemoglobin Hemorrhage - chemically induced Hemorrhage - epidemiology High density lipoprotein Humans Ischemia Low density lipoprotein Metabolic parameters Plasma Rivaroxaban - therapeutic use Stroke Stroke - epidemiology Thromboembolism Triglycerides Warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!